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Abstract 
Only 6 cases with an association of disseminated superficial porokeratosis with dermal 
amyloid deposits are reported in the literature. We present the case of a 76-year-old 
woman who presented with a disseminated superficial porokeratosis. Histological 
examination revealed amyloid deposits in the upper dermis, which were typed with 
routine HE stains, Congo red stains and anticytokeratin antibodies (AE1-AE3 and CK5). 
Positive staining with Congo red and, moreover, with CK5 (a cytokeratin strongly 
represented in the basal cell layer of the epidermis) indicates an epidermal origin of this 
protein. 
 
Introduction 
Porokeratoses are a group of cutaneous entities of unknown etiology, characterized by 
disordered epidermal keratinization and, at histological examination, by the presence of 
coronoid lamella, a column of parakeratotic cells extending through the stratum corneum 
[1]. 
Disseminated superficial porokeratosis (DSP) is a distinct form of porokeratosis that, 
clinically, is characterized by numerous, small, superficial keratotic papules with 
verrucoid aspects, an atrophic center and peripheral keratotic border. Sometimes DSP can 
be associated with dermal amyloid deposits [1]. Only 7 cases of this association have been 
described in the literature (table 1) [2]. 
We report a eighth case of this type and an atypical immunohistochemical method 
used to characterize the amyloid substance.  
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Case Report 
A 76-year-old woman was referred to our Department in June 1999. She reported a 20 years’ history 
of an erythematous and squamo-papular eruption located on the extremities, without itching or pain. 
The patient had noted a progressive extension of these lesions in the last year and an exacerbation of the 
lesions during the summer. Upon physical examination, numerous papules with a size of less than 15 
mm, an atrophic center and hyperkeratotic borders were distributed on the neck, chest and extremities. 
Palms, soles, mucous membranes and nails were spared, and the patient denied any family history of 
similar skin lesions. She had no other symptoms and laboratory tests were all normal or negative. 
We examined a skin biopsy that revealed atrophy of the epidermis with hyperorthokeratosis and 
presence of homogeneous and compact cornoid lamella of keratin, typically oriented sideways with 
respect to the epidermal tissue (fig. 1a). The superficial dermis showed a slight chronic inflammatory 
infiltrate with vascular ectasia and edema. Moreover, in the papillary dermis a compact deposit of a 
cellular eosinophilic material suspicious for amyloid was observed (fig. 1b). 
To demonstrate the epithelial origin of the amyloid, we performed two immunohistochemical 
stainings by using specific MoAbs to pan-cytokeratin AE1-AE3. Interestingly, there was a striking 
difference between the two results: in fact, the acellular deposits, mentioned above, were negative for 
CKAE1-AE3, whereas a strong immunoreactivity was demonstrated for CK5, supporting a specific 
origin of the amyloid substance from the basal cell layer of the epidermis (fig. 1c). 
Discussion 
In 1937, Andrews first described DSP and introduced this term to indicate a clinical 
variant of Mibelli’s porokeratosis. Later, Chernoski and Freeman proposed a possible 
actinic etiology of this dermatosis and coined the term disseminated superficial ‘actinic’ 
porokeratosis (DSAP). Nowadays, this term is generally accepted in European 
dermatological literature, and this definition is based on clinical and histological findings. 
Dermatological manifestations are typically confined to sun exposed areas, with actinic 
induction and exacerbations [2]. 
In the literature, two types of localized cutaneous amyloidosis (LCA) are described: 
primary LCA (macular amyloidosis and lichen amyloidosis), which is not associated with 
other dermatoses or systemic involvement, and secondary LCA, which is associated with 
inflammatory, hamartomatous or neoplastic skin disorders [2]. 
The mechanism by which DSP induces dermal amyloid deposits is not clear, but 
Piamphongstant et al. first suggested that this process can derive from degenerated 
epidermal keratinocytes [2]. We hypothesize that a mutant keratinocyte clone is 
responsible for induction of porokeratotic lesions, because these necrotic epidermal 
keratinocytes (colloid bodies) might be transformed into amyloid by dermal macrophages 
and fibroblasts [3]. Immunohistochemical staining has shown an overexpression of p53 
protein in porokeratotic lesions; this is a tumor suppressor protein, an important 
gatekeeper and effector of the cell cycle. Mutations of the p53 gene in all forms of 
porokeratosis, also in DSAP, create a permissive state of uncoordinated cell cycling, and 
predispose cells to death [4]. 
In our case, the lack of systemic involvement led to our hypothesis of a secondary 
dermal deposition of amyloid proteins and the existence of a close relationship between 
these two processes. This hypothesis was confirmed by positive staining with Congo red 
and immunohistochemical staining with the anticytokeratin MoAbs strongly positive for 
CK5, just below the epidermal porokeratotic zone in close proximity to the cornoid 
lamella. This cytokeratin is, in fact, strongly represented in the basal cell layer and these  
Case Rep Dermatol 2009;1:35–38 
DOI: 10.1159/000236037 
Published online: September 12, 2009  © 2009 S. Karger AG, Basel 
ISSN 1662–6567 
www.karger.com/cde 
 
 
37
results indicate that the dermal deposits were amyloid originating from the epidermis 
(type II keratin). 
Nowadays, more studies are necessary to clarify the exact mechanism that leads to 
secondary deposition of dermal amyloid in porokeratotic disease and the frequency of 
this association. We also suggest utilization of MoAbs for CK5 as a first-line target in 
these conditions, encouraged by the immediate and strong positivity of this protein in 
immunohistochemical studies, whereas pan-cytokeratin at first produced negative results. 
 
 
 
Table 1. DSP with amyloid deposits: a summary of the reported cases 
 Piamphongstant 
and 
Sittapairoachana, 
1974 [5] 
Stefanato 
et al., 
1993 [6] 
Yasuda 
et al., 
1996 [7] 
1st case 
Yasuda 
et al., 
1996 [7] 
2nd case 
Amantea 
et al., 
1998 [3] 
Demitsu 
and Okada, 
1999 [8] 
Kim et al., 
2000 [2] 
Age/sex 51/F  32/F  63/M  60/M  72/M  63/M 88/M 
Age at onset  6th decade  4th decade  5th decade  6th decade  7th decade  adolescence  7th decade 
Duration  7 years   1 month  20 years   2 years  3–4 years  n.d.  20 years 
Pruritus n.d.  none  slight  present  none  n.d.  severe 
Family history  n.d.  negative  n.d.  n.d.  negative  negative  daughter 
Treatment n.d.  topical 
steroid/ 
etretinate 
topical 
DMSO 
topical 
DSMO 
topical 
steroid 
n.d. cryosurgery    topical 
steroid 
antihistamine
cryosurgery 
Results   not 
improved 
improved worsened    improved  improved   
n.d. = Not described; DSMO = dimethyl sulfoxide. 
 
 
 
 
Fig. 1. a Hyperkeratosis and coronoid lamella. b Eosinophilic, acellular deposits in the dermis. c Strong 
immunoreaction of amyloid for CK5. 
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